Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-26-000301

Options or other derivatives

  • Director acquired 5,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nuechterlein Carole · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +5,860 5,860 D
Loading xslF345X06/form4.xml…